Epidemiologists are hosing down concerns over the efficacy of AstraZeneca’s COVID-19 vaccine in the elderly despite a move in Germany not to recommend it for this age group.

The German vaccine committee on Thursday issued a draft advisory that the vaccine should be endorsed only for people aged 18-64, sparking global concern — including in Australia where GPs are being invited to deliver it once approved by the TGA.